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Abstract  
 
T cell protective immunity is associated with multifunctional memory cells that produce 
several different cytokines. Currently, our understanding of when and how these cells are 
generated is limited. We have used an influenza virus mouse infection model to investigate 
whether the cytokine profile of memory T cells is reflective of primary responding cells or 
skewed towards a distinct profile. We found that, in comparison to primary cells, memory T 
cells tended to make multiple cytokines simultaneously. Analysis of the timings of release of 
cytokine by influenza virus-specific T cells, demonstrated that primary responding CD4 T 
cells from lymphoid organs were unable to produce a sustained cytokine response. In 
contrast CD8 T cells, memory CD4 T cells, and primary responding CD4 T cells from the 
lung produced a sustained cytokine response throughout the restimulation period. Moreover, 
memory CD4 T cells were more resistant than primary responding CD4 T cells to inhibitors 
that suppress T cell receptor signalling. Together, these data suggest that memory CD4 T 
cells display superior cytokine responses compared to primary responding cells. These data 
are key to our ability to identify the cues that drive the generation of protective memory CD4 
T cells following infection. 
  
 
 
 
Introduction  
Immunological memory provides superior immune protection from pathogens for two 
reasons. First, there are more pathogen specific cells present in the memory as compared to 
the naïve compartment. Second, memory cells are intrinsically different from naïve cells: 
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they are located in peripheral organs as well as secondary lymphoid organs; are more 
sensitive to activation signals; and provide a more tailored response [1, 2].  
 
This tailored response is defined by the effector cytokines T cells express and is one of the 
main mechanisms of T cell-mediated immune protection. The ability to track antigen specific 
T cells via their cytokine profile is essential to understand their protective potential. This 
cytokine profile is shaped by pathogen-triggered signals during the primary response [3]. 
These signals drive the effector cytokine production, such as interferon (IFN)-, interleukin 
(IL)-4 or IL-17, most effective at co-ordinating pathogen control [2, 4].  
 
Multiple studies demonstrate that memory T cells can develop from differentiated, effector 
cytokine producing cells [5-8]. However, there is also evidence that the least differentiated 
cells are more likely to enter the memory pool suggesting that these cells may dominate the 
memory pool [9-11]. Such cells may not, however, offer the best protection. The most 
effective memory T cells are thought to be cells that produce high levels of a range of 
different cytokines, termed poly or multifunctional T cells [12-15]. While it is not yet clear why 
multifunctional memory T cells offer the most effective protection, their ability to produce 
cytokines, such as IFN-, that activate innate immune cells, and IL-2, which aids T cell 
proliferation, means they both drive and sustain secondary responses.   
 
Understanding the relationship between primary responding and memory T cells will aid in 
the design of vaccines that aim to drive protective immunological memory. A major hurdle in 
characterising pathogen specific T cells is in their identification. Most studies use either 
monoclonal T cell receptor (TCR) transgenic CD4 T cells or identify endogenous T cells 
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specific to a single epitope [16-20]. This narrow focus limits the research scope, especially 
as CD4 T cells are thought to respond to a diverse range of pathogen epitopes [21, 22]. 
 
Here we address how the cytokine profile of endogenous polyclonal pathogen specific 
effector CD4 and CD8 T cells relates to that of subsequently generated memory T cells. We 
find that, in comparison to primary effector T cells, memory CD4 T cells have an increased 
tendency to be multifunctional, display a more sustained cytokine response, and are less 
sensitive to inhibitors of TCR signalling. Memory CD8 T cells are also more likely to be 
multifunctional than primary responding cells. However, primary and memory CD8 T cells 
are similar in the sustainability of the cytokine response and their sensitivity to TCR 
signalling inhibitors.   
 
Results 
 
Cytokine producing CD4 T cells decline most dramatically in the lung 
The primary immune response is usually followed by a contraction phase in which most 
activated T cells undergo cell death [23]. Highly differentiated effector cytokine producing T 
cells are thought to be more likely to undergo apoptosis than less differentiated IL-2 
producing cells [18].  Moreover, memory cells in peripheral tissue are thought to be more 
differentiated than those in lymphoid organs and the bone marrow has been proposed as a 
site of memory T cell maintenance [24-29]. 
 
To address these assumptions, we examined the ex vivo cytokine responses of CD4 and 
CD8 T cells isolated from mice infected with influenza A virus (IAV) at the peak of the 
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primary responses, day 9, and at two memory timepoints, days 30 and 75. We identified 
IAV-specific T cells by their ability to produce cytokine following ex vivo restimulation with 
bone marrow derived dendritic cells (bmDCs) incubated overnight with IAV. Incubation of 
bmDCs with IAV (IAV+ bmDCs) caused minor upregulation of MHC II and costimulatory 
molecules (Supplementary Figure 1).    
 
In all organs, we identified populations of IFN-, TNF-, and IL-2 IAV-specific T cells 
(Supplementary Figure 2 and 3). Overall, the number of cytokine+ IAV-specific CD4 T cells 
declined from the peak response at day 9 and then numbers levelled out (Figure 1A). The 
decline in numbers of cytokine producing CD4 T cells was most obvious in the lung for IFN-
+ cells and least obvious in the bone marrow for TNF- and IL-2+ cells, although this organ 
contained the smallest numbers of cytokine+ cells. Similarly, IAV-specific CD8 T cells 
declined from day 9 to day 30, although the small number of IL-2+ cells remained fairly 
constant. After the contraction phase, the numbers of cytokine+ CD8 T cells largely 
remained steady. For CD4 T cells, the memory cells were predominantly found in the spleen 
and mediastinal lymph node, while CD8 cytokine+ T cells were mainly found in the spleen.  
 
The dramatic decrease of T cells in the lung could have been due to a large population of 
IAV-specific T cells within the lung vasculature at day 9. However, by labelling these cells in 
vivo with fluorescently labelled anti-CD45 shortly before the tissues were harvested [30], we 
found that more IAV-specific cytokine+ T cells were found in the blood at memory as 
compared to primary time points (Figure 1B). 
 
Together these data confirm that, as expected, cytokine+ T cells contract from the peak of 
disease. However, our data suggests that cytokine+ memory T cells in lymphoid organs are 
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just as likely as those from peripheral tissues to make effector cytokines. We did not observe 
preferential survival of memory CD4 or CD8 T cells in the bone marrow and, given the small 
numbers of memory CD4 T cells present in the bone marrow did not pursue these cells 
further. 
 
Memory T cells are more likely to be multifunctional than primary responding T cells 
Given that IL-2, particularly autocrine IL-2, is thought to support memory T cell development 
[18], we expected to see an increased proportion of IL-2 producing T cells in the memory 
pool. We did not observe a dramatic shift towards IL-2+ IAV-specific CD4 T cells within the 
memory pool (Figure 1). Rather, similar numbers of IAV-specific cells identified by any one 
of the three cytokines suggested that these may be the same cells that produce all three 
cytokines. To address this, we examined the combined cytokine producing capacity of 
individual cells in both the primary and memory response. 
 
For CD4 T cells, we observed a consistent increase in the proportion of multifunctional 
cytokine+ cells that produced IFN-, TNF-, and IL-2 in all three organs examined (Figure 2). 
This shift was associated with a reduction in single IFN-+ cells. At day 9, minimal IL-2 was 
made by CD8 T cells. However, memory CD8 T cells are more likely to make IL-2 than 
primary responding cells [11, 31, 32]. We confirmed this and found that, as with the CD4 T 
cell response, the memory CD8 T cell pool was more likely to contain multifunctional CD8 T 
cells.  
 
The increase in multifunctional T cells in the memory pool observed in the lung could have 
been due to the increased proportion of cells in circulation rather than a shift in 
multifunctionality in cells within the lung itself. However, for both CD4 and CD8 T cells we 
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found similar proportions of multifunctional cells within the i.v. injected CD45 positive and 
negative fractions 30 days post-infection. This demonstrates that circulating and tissue 
resistant populations displayed similar multifunctional characteristics and supports the idea 
that memory cells, regardless of location, shift towards increased multifunctionality (Figure 
2D and Supplementary Figure 4). 
 
The dynamics of T cell cytokine release reveals functional maturation of CD4, but not CD8, T 
cells 
To investigate the dynamics of cytokine production by T cells, we analysed the kinetics of 
cytokine secretion during the ex vivo restimulation. T cells from mice infected with IAV 9 or 
30 days previously were activated with IAV+ bmDCs, and Golgi Plug added at the start of 
the incubation, two or four hours later. Cells were analysed two hours after the addition of 
Golgi Plug. 
 
Primary responding and memory CD8 T cells produced sustained or increased levels of 
cytokine, most notably IFN-, throughout the restimulation period. However, primary 
responding CD4 T cells from lymphoid organs produced less cytokine at 4-6 hours than at 2-
4 hours post-stimulation (Figure 3: IFN- and Supplementary Figure 5: TNF- and IL-2). 
These data suggest that anti-viral CD4 T cells have a less sustained cytokine response than 
CD8 T cells.  
 
In contrast, lung primary responding CD4 T cells produced sustained levels of cytokine 
suggesting that CD4 T cells from peripheral organs have altered regulation of their cytokine 
responses compared to those from lymphoid organs (Figure 3 and Supplementary Figure 5). 
Interestingly, memory CD4 T cells, regardless of their source, displayed sustained cytokine 
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responses with similar percentages of cells producing cytokine throughout the restimulation 
culture. These data suggest that memory CD4 T cells are functionally more superior than 
primary responding CD4 T cells. 
 
An alternative explanation for this observation is that the primary responding pool contains a 
subset of T cells that only produce cytokine between 2-4 hours following restimulation but 
that this subset is missing from the memory pool. To investigate this, we calculated the 
proportion of the number of CD4 T cells producing IFN- at 2-4 hours out of the number of 
IFN-+ CD4 T cells found throughout the whole restimulation period (i.e. Golgi plug present 
from 0-6hours). These percentages were similar between the primary and memory CD4 T 
cells regardless of which organ was examined (Supplementary Figure 6). These data 
suggest that there are similar proportions of the whole population responding at 2-4hours in 
the primary and memory CD4 T cells.  
 
By examining cytokine production across the restimulation culture, we were able to 
determine whether triple, double and single cytokine producing T cells had similar kinetics of 
cytokine production. This was the case for CD4 T cells, with all populations present at the 
three time points examined (Figure 3C). A similar pattern was found for CD8 T cells, 
although the percentages of multifunctional cells in the primary response were very low. 
These data show that multifunctional cells are indeed able to produce all three cytokines 
simultaneously and that these cells have similar kinetics of cytokine release as double and 
single cytokine producers at primary and memory time points. 
 
PI3kinase inhibitors reveal altered cytokine responses by primary responding and memory 
CD4 T cells 
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The different cytokine profiles of IAV-specific CD4 T cells between organs and time points 
prompted us to investigate whether cytokine production was regulated distinctly in these 
cells. PI3Kinases (PI3K) play a key role in relating T cell activation to cytokine production 
[33]. Immune cells uniquely express two of the four isoforms of type I PI3K: PI3K-, engaged 
by receptor tyrosine kinases, such as those stimulated by T or B cell receptor ligation; and 
PI3K-, usually activated by G-protein coupled receptors such as chemokine receptors [34]. 
These differences in signalling pathways predict that inhibitors that target PI3K-, rather than 
PI3K-, are more likely to reduce T cell cytokine responses. 
 
To test the requirement for different PI3K isoforms for cytokine production, we added 
PI3Kinase inhibitors that target either PI3K- or PI3K- to the restimulation co-culture. 
Cytokine responses by primary responding and memory IAV-specific CD4 and CD8 T cells 
from all organs were consistently reduced by the PI3K- inhibitor (Supplementary Figure 7). 
In contrast, the PI3K- inhibitor had little or no effect on cytokine production.  
 
To investigate whether the inhibitors affected the three different cytokines distinctly and 
whether these were different between primary and memory cells, we calculated the 
percentages of cytokine response for each organ from each sample to that in the relevant 
DMSO control (Figure 4). For both CD4 and CD8 T cells, IFN- tended to be least affected 
and TNF- most likely to be reduced for CD4 T cells and IL-2 most reduced for CD8 T cells. 
Memory CD4 T cells from the spleen and lung were less sensitive to the inhibitors than 
primary T cells. This pattern was much less apparent for memory CD8 T cells with only IL-2 
responses in the lung and mediastinal lymph node less affected in the memory as compared 
to the primary response by the P3K- and PI3K- inhibitors respectively.  
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We also examined how the inhibitors affected the proportion of single, double and triple 
cytokine producing T cells (Figure 5). As IFN- was least affected by the inhibitors, it was not 
surprising that the proportion of IFN- single+ CD4 T cells increased in the presence of the 
PI3K- inhibitor. This pattern was apparent in all organs in the primary response but only 
slightly altered in memory CD4 T cells from the mediastinal LN and not at all in memory CD4 
T cells from the spleen and the lung.  
 
In contrast, the effects of the inhibitors were less clearly distinct between primary and 
memory CD8 T cells. Triple cytokine producing cells were slightly reduced by the PI3K- 
inhibitor in spleen and lung in primary CD8 T cells and not at all in memory CD8 T cells. 
Surprisingly the PI3K- inhibitor reduced the triple cytokine positive population in in the 
memory T cells isolated from the spleen and mediastinal LN. Overall, these data again 
highlight the functional superiority of CD4, but not CD8, T cell cytokine production in the 
memory as compared to the primary pool. 
 
 
Discussion 
 
Our data demonstrate that memory cytokine producing IAV-specific CD4 T cells have distinct 
characteristics from the population of activated CD4 T cells from which they are generated. 
Memory CD4 T cells were much more likely to demonstrate characteristics of multifunctional 
T cells, produced sustained cytokine responses, and were less reliant on signals mediated 
by PI3Kinase- to produce cytokine. Interestingly, primary responding lung CD4 T cells did 
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display a sustained cytokine response, suggesting that these cells may be regulated 
distinctly from those in lymphoid organs.  
 
In contrast, while we confirm that CD8 memory T cells are more likely to produce IL-2 [11, 
31, 32], their sensitivity to PI3Kinase inhibitors was broadly similar to primary responding 
cells. Moreover, primary and memory CD8 T cells displayed similar kinetics in their cytokine 
secretion with a sustained or increasing response evident throughout the six hour 
restimulation. Together, these data show that, based on these parameters, memory CD4, 
but not CD8 T cells display superior behaviours than primary responding cells.  
 
In all organs, we found that T cells could produce effector cytokines, indicating that effector 
memory T cells were as likely to be found in lymphoid as non-lymphoid organs. The 
increased proportion of triple cytokine+ CD4 and CD8 T cells suggests that these cells may 
preferentially survive. Alternatively, these cells may mature into this phenotype following 
contraction, or have improved survival over time. This last hypothesis is supported by the 
continued increase in the proportion of multifunctional cells from day 30 to day 75 in some 
organs. It is experimentally difficult to discriminate between these possibilities. There are no 
surface markers that discriminate between the cytokine+ populations and neither cytokine 
secretion assays nor reporter mice can discriminate between single, double and triple 
producers. 
 
It is not clear why multifunctional T cells increase within the memory pool. Potentially the 
production of IL-2 provides autocrine survival signals [18]. However, if autocrine IL-2 
production was sufficient, we would expect an increased predominance of IL-2 single or 
double producing cells. This was not the case suggesting that other factors, potentially 
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working with IL-2, promote memory T cell generation and/or survival. Whether these factors 
are directly linked to the co-production of these three cytokines or multifunctional cytokine 
production is merely a marker, is currently unclear. One potential explanation is that the 
repertoire of the memory pool is skewed towards specificities that are more likely to be 
multifunctional. However, there is little evidence for a loss of breadth within the IAV CD4 T 
cell response from the peak to day 60 post-infection [22].  
 
Previous studies have compared the cytokine profiles of activated and memory CD4 T cells 
and found similar cytokine profiles between primary and memory populations [35, 36]. In 
these cases, T cells in lymphoid organs were analysed and only a single epitope examined. 
This limits the breadth of these analyses potentially explaining differences with our data. 
Indeed, precursor frequency and epitope specificity are likely to influence cytokine response 
[19].  
 
We believe analysing a polyclonal antigen-specific population, rather than a single epitope 
response, is an advantage. It is likely, however, that our assay does not identify all 
responding IAV-specific T cells as some epitopes may not be generated by the bmDCs [37] 
and we are unable to identify IAV-specific T cells that do not produce cytokine. Our data on 
CD8 T cells do, however, correlate with findings from studies using immunodominant IAV 
epitopes [11, 31, 32]. A further caveat to our study is that the longest time period of in vitro 
reactivation examined was six hours. It will be important to examine longer reactivation 
periods enabling a greater understanding of the difference between primary responding and 
memory T cells in terms of their ability to produce a sustained cytokine response.  
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The reduced sensitivity of memory CD4 T cells to the PI3K inhibitors and their more 
sustained cytokine response suggests that these cells are less reliant on strong activation 
signals than primary responding cells. This may be a consequence of increased expression 
of the key signalling molecule, Zap70 [38], or altered association of signalling molecules 
within lipid rafts [39]. Previous studies demonstrated reduced T cell activation and cytokine 
responses in either the absence of PI3Ks or in the presence of inhibitors [40-44]. However, 
in these studies, the effect of the loss of PI3K signalling on cytokine production by CD4 T 
cells could not be uncoupled from initial effects on T cell priming. In contrast, we have 
directly demonstrated that inhibition of PI3K- reduces TCR driven cytokine responses.  
 
Currently, PI3K inhibitors are being tested in clinical trials for chronic inflammatory lung 
diseases including chronic obstructive pulmonary disease and asthma [45]. IAV-triggered 
exacerbations are a major cause of hospitalisation in these patients [46].  As IFN-+ IAV-
specific memory CD4 and CD8 T cells have been associated with protection from disease 
following IAV infection in humans, it is unlikely that PI3K inhibitors will interfere with 
protective T cell memory [28, 47-50]. In contrast, primary virus-specific immune responses 
may be more likely to be reduced by PI3K inhibitors and the cells most likely to be affected 
are those most associated with immune protection, multifunctional cytokine producing T 
cells. Choosing the most effective PI3K inhibitor that has the least impact on T cell cytokine 
production is an important clinical consideration. The PI3K- inhibitor had only a limited 
effect on T cell cytokine responses suggesting it offers a good compromise.  
 
In summary, our data demonstrate that the memory T cell pool is not simply a mirror image 
of the primary response. While the location of these two populations is similar, memory CD4 
and CD8 T cells have a greater capacity to make broader cytokine responses. CD4 T cells 
were also altered in their sensitivity to TCR signalling inhibitors and produced a more 
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sustained cytokine response, suggesting functional maturation as these cells develop into 
memory cells. These novel findings pave the way for an improved understanding of the 
signals that regulate memory CD4 T cell generation.  
 
Materials and Methods 
 
Animals and infections 
10 week old female C57BL/6 mice were purchased from Envigo (UK). They were maintained 
at the University of Glasgow under standard animal husbandry conditions in accordance with 
UK home office regulations (Project License P2F28B003) and approved by the local ethics 
committee. Following one week of acclimatisation, the mice were briefly anesthetised using 
inhaled isoflurane and infected with 200-300 plaque forming units of IAV strain WSN in 20l 
of PBS intranasally (i.n.). IAV was prepared and titred in MDCK cells. Infected mice were 
weighed daily. Any animals that lost more than 20% of their starting weight were removed 
from the study and humanely euthanised. Group sizes were based on previous experiments 
considering the known variability of the anti-viral T cell response, animals that did not lose 
any weight following infection were excluded. 
 
Tissue preparation 
Where indicated, mice were injected intravenously with 1g of anti-CD45 (30-F11) labelled 
with Alexa 488 (eBioscience) and euthanised by cervical dislocation 3 minutes later. 
Alternatively, mice were euthanised with a rising concentration of carbon dioxide and 
perfused with PBS-5mM EDTA to remove blood cells from the lungs. Spleen and mediastinal 
lymph nodes were processed by mechanical disruption. Single cell suspensions of lungs 
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were prepared by digestion with 1mg/ml collagenase and DNAse (Sigma) for 40 minutes at 
37C. At day 30, too few cells were recovered from the MLN for the analysis of PI3Kinase 
inhibitor sensitivity. Therefore, each of the organs from two mice that had lost similar 
amounts of weight were combined to provide one day 30 sample. In the PI3Kinase inhibitor 
experiments, T cells were isolated using Stemcell mouse T cell isolation kits following the 
manufacturer’s recommendations. 
 
Influenza virus and control antigen 
The IAV antigen was prepared using a similar protocol as descried [51]. Briefly, T75 flasks of 
80% confluent MDCK cells were incubated for one hour at 37C 5% CO2 with or without an 
MOI of 0.001 IAV WSN. Virus or control inoculums were removed and cells incubated for a 
further two days in 12ml of OPTI-MEM supplemented with Pen/Strep and 1.0 µg/mL trypsin-
TPCK. 48 hours later, the cells were harvested, spun down, resuspended in 0.1M glycine 
buffer containing 0.9% NaCl, pH9.75 and shaken at 4C for 20 minutes, incubated in a 
sonication bath for 10 seconds intervals 4 times before centrifugation at 2000rpm for 20 
minutes at 4C. Supernatant was aliquoted and frozen at -80C.  
 
Bone marrow DCs 
BmDCs were prepared as described [52]. Briefly, bone marrow cells were flushed from the 
tibias and femurs of female C57BL/6 mice and red blood cells removed. Cells were cultured 
in complete RPMI (RPMI with 10% foetal calf serum, 100g/ml penicillin-streptomycin and 
2mM L-glutamine) at 37C 5% CO2 in the presence of GM-CSF (prepared from X-63 
supernatant [53]) with media supplemented on day 2 and replaced on day 5. On day 7, DCs 
were harvested, incubated overnight with either control antigen or IAV antigen (MOI of 0.3). 
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Ex vivo restimulation  
Single cell suspensions were co-cultured with bmDCs in complete RMPI at a ratio of 
approximately 10 T cells to 1 DC in the presence of Golgi Plug (BD Bioscience). Co-cultures 
were incubated at 37C, 5% CO2 for 6 hours unless stated. PI3K inhibitors were used at: 
PI3K-: 100nM; PI3K-: 300nM. These concentrations were selected as they are mid-range 
for the concentrations known to affect T cell responses. All inhibitors were 300-1000-fold 
selective over other PI3K family members.  
 
Flow cytometry 
Cells were harvested and following incubation with Fc block (homemade containing 24G2 
supernatant and mouse serum) surface stained with anti-CD4 APC-Alexa 780 (eBioscience; 
clone: RM4-5), anti-CD44 PerCP-Cy5.5 (eBioscience; clone: IM7), CD8 PeCy7 
(eBioscience; clone: 53-6.7), and “dump” antibodies: B220 (clone: RA3-6B2) and MHC II 
(clone: M5114) both on eFluor-450 (eBioscience) for 20 minutes at 4C. Cells were stained 
with a fixable viability dye eFluor 506 (eBioscience) as per the manufacturer’s 
recommendations. Cells were fixed with cytofix/cytoperm (BD Bioscience) for 20 minutes at 
4C and stained in permwash buffer with anti-cytokine antibodies for one hour at room 
temperature (anti-IFN- PE (clone: XMG1.2;), anti-TNF Alexa-Fluor-488 (clone: MP6-XT22) 
anti-IL-2 APC (clone: JES6-5H4) all from eBioscience. Following washing with permwash 
buffer, samples were acquired on a BD LSR or Fortessa and analysed using FlowJo (version 
10 Treestar). Data are presented as required for MIFlowCyt. 
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Statistical analysis 
Data were analysed using Prism version 7 software (GraphPad). Differences between 
groups were analysed by paired or unpaired ANOVAs as indicated in figure legends. In all 
figures * represents a p value of <0.05; **: p<0.01, ***: p<0.001, ****: p<0.0001. 
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Figure Legends 
Figure 1: Cytokine producing IAV-specific memory CD4 and CD8 T cell numbers 
stabilise in lymphoid organs but continue to decline in the lung  
C57BL/6 mice were infected with IAV and 9, 30 or 75 days later the IAV-specific cytokine+ T 
cells were examined by flow cytometry following 6 hours restimulation with IAV+ bmDCs. 
Mice were injected with fluorescently labelled anti-CD45 shortly before tissues were 
harvested. In A, each point represents the mean of 8-9 mice combined from two 
independent experiments; error bars are SEM and numbers are the absolute numbers of 
indicated cell types present in each organ. In B, the percentages of cytokine+ CD4 and CD8 
T cells that bound to the injected anti-CD45+ and were IFN-γ+ at days 9 and 30 are shown; 
each point represents one mouse and the line shows the mean of the group. Data are 
combined from 3 experiments with 3-4 mice per group. 
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Figure 2: Multifunctional CD4 and CD8 T cells increase in proportion from the primary 
to the memory pool 
Mediastinal lymph nodes, spleens and lungs were taken from C57BL/6 mice 9, 30 and 75 
days post-infection with IAV. The percentages of IFN-+ CD4 and CD8 T cells that also 
expressed IL-2 and/or TNF- were determined following 6 hours stimulation with IAV+ 
bmDCs. In A, spleen cells are gated on live CD4+ or CD8+ dump negative lymphocytes that 
are IFN-γ+; representative FACS plots from 3 experiments with 3-5 mice per group. In B and 
C data are from two time course experiment with a total of 8-9 mice/group/timepoint. In D, 
mice infected with IAV 30 days previously were injected i.v. with fluorescently labeled anti-
CD45 3 minutes prior to euthanasia and lung cells stimulated and examined as in A. and 
numbers show mean+SD of the triple+ population. Data in D are from 3 experiments with a 
total of 10 mice. Samples were analysed by ANOVA followed by a Tukey’s multiple 
comparison test: *: p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. 
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Figure 3: Memory CD4 T cells demonstrate more sustained cytokine production than 
primary responding cells 
Mediastinal lymph nodes, spleens and lungs were taken from C57BL/6 mice 9 and 30 days 
post-infection with IAV and reactivated in vitro with IAV+ bmDCs for 2, 4 or 6 hours in the 
presence of Golgi plug for the last 2 hours of culture. The percentages of IFN-+ CD4 (A) 
and CD8 T cells (B) or IFN-+ CD4 and CD8 T cells that also expressed IL-2 and/or TNF- 
(C) were examined at the indicated time points. Error bars show SEM. Data are combined 
from 3 experiments/timepoint with 4 mice/timepoint. Samples were analysed using a 
Friedman’s paired test followed by a Dunn’s multiple comparison test *: p<0.05; **p<0.01; 
***p<0.001; ****p<0.0001. 
Westerhof et al                                                 
This article is protected by copyright. All rights reserved. 30 
 
Westerhof et al                                                 
This article is protected by copyright. All rights reserved. 31 
Figure 4: Memory CD4 T cell cytokine production is less affected by PI3Kinase 
inhibitors than primary responding CD4 T cells 
T cells from the spleen, Med LN and lung were isolated from C57BL/6 mice infected with IAV 
either 9 or 30 days previously and reactivated with IAV+ bmDCs for 6 hours in the presence 
of Golgi plug and the indicated PI3Kinase inhibitor. The percentages of cytokine+ CD4 (A) 
and CD8 (B) T cells in each sample in comparison to that sample’s DMSO control was 
calculated. Data are combined from 3 independent experiments at each timepoint with 4-5 
samples per experiment per timepoint, expect that some samples were removed from the 
primary responses due to lack of IL2+ cells in the DMSO control: one sample removed from 
the CD4 T cell lung analysis; one sample removed from the CD8 Med LN analysis; and two 
from the lung analysis. Comparisons between cytokines within a timepoint were made using 
paired Friedman test with Dunn’s multiple comparison; comparisons between timepoints 
were calculated using a Kruskal-Wallis with Dunn’s multiple comparison test.  *: p<0.05; 
**p<0.01; ***p<0.001; ****p<0.0001. 
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Figure 5: Multifunctional memory CD4 T cells are less affected by PI3Kinase inhibitors 
than primary responding cells 
T cells from the spleen, Med LN and lung were isolated from C57BL/6 mice infected with IAV 
either 9 or 30 days previously and reactivated with IAV+ bmDCs for 6 hours in the presence 
of Golgi plug and the indicated PI3Kinase inhibitor. The percentages of IFN-γ+ CD4 (A) and 
CD8 (B) T cells that also produced TNF- and/or IL-2 were examined. Data are combined 
from 3 independent experiments at each timepoint with 4-5 samples per experiment per 
timepoint. Samples were analysed using an ANOVA with Bonferroni’s multiple comparison 
test comparing each inhibitor to the DMSO control *: p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001. 
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